Dave sits down with nurse practitioner and former Retatrutide clinical trial participant David White to break down the biggest obesity headlines from the 2026 American Diabetes Association Conference. Together, they explore the latest data on Retatrutide's potential to deliver bariatric surgery-level weight loss, improve cardiometabolic health, and reshape the future of obesity and type 2 diabetes treatment.otplinks.com
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from On The Pen GLP-1 News
Retatrutide Biologic Battle: The Story Gets Bigger
GLP-1 Showdown: Inside The High Stakes War over Patients
Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know
Compound GLP-1 Poll STUNS THE INTERNET!
Get summaries like this every morning.
Free AI-powered recaps of On The Pen GLP-1 News and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.